New hope for advanced lung cancer patients in clinical trial

NCT ID NCT06667908

Recruiting now Disease control Sponsor: Johnson & Johnson Enterprise Innovation Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing whether adding an experimental drug called JNJ-90301900 to standard chemotherapy and radiation treatment improves outcomes for people with advanced, inoperable lung cancer. The trial will involve 130 participants who will receive either the standard treatment alone or the standard treatment plus the experimental drug. Researchers will measure how well tumors shrink and how long patients remain progression-free.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Antoni van Leeuwenhoek
RECRUITING

Amsterdam, 1066 CX, Netherlands
Clinica Univ. de Navarra
RECRUITING

Pamplona, 31008, Spain
Emory University Winship Cancer Institute
RECRUITING

Atlanta, Georgia, 30306, United States
FirstHealth of the Carolinas
RECRUITING

Pinehurst, North Carolina, 28374, United States
Fundacao Pio XII
RECRUITING

Barretos, 14784 400, Brazil
Gustave Roussy
RECRUITING

Villejuif, 94805, France
Hopital De La Cavale Blanche
RECRUITING

Brest, 29200, France
Hopital Nord Marseille
RECRUITING

Marseille, 13015, France
Hopital Tenon
RECRUITING

Paris, 75020, France
Hosp. Clinico Univ. de Santiago
RECRUITING

Santiago de Compostela, 15706, Spain
Hosp. Univ. 12 de Octubre
RECRUITING

Madrid, 28041, Spain
Hosp. Univ. I Politecni La Fe
RECRUITING

Valencia, 46026, Spain
Institut Curie
RECRUITING

Paris, 75248, France
MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States
Macquarie University
RECRUITING

North Ryde, 2109, Australia
Marmara University Pendik Training Hospital
RECRUITING

Istanbul, 34899, Turkey (Türkiye)
Memorial Sloan Kettering Cancer Center
RECRUITING

New York, New York, 10065, United States
NYU Langone Health
RECRUITING

New York, New York, 10016, United States
Oregon Health And Science University
RECRUITING

Portland, Oregon, 97239, United States
Orlando Health Cancer Institute
RECRUITING

Orlando, Florida, 32806, United States
Prince of Wales Hospital
RECRUITING

Shatin, Hong Kong
Radboud Umcn
RECRUITING

Nijmegen, 6525 GA, Netherlands
Royal Melbourne Hospital
RECRUITING

Parkville, 3050, Australia
Sakarya University Training and Research Hospital
RECRUITING

Sakarya, 54100, Turkey (Türkiye)
Sir Charles Gairdner Hospital
RECRUITING

Nedlands, 6009, Australia
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein
RECRUITING

São Paulo, 05651 901, Brazil
Sociedade Beneficente de Senhoras Hospital Sirio Libanes
RECRUITING

São Paulo, 01308 050, Brazil
The Affiliated Cancer Hospital of Shandong First Medical University
RECRUITING

Jinan, 250117, China
University College London Hospitals
RECRUITING

London, NW1 2BU, United Kingdom
University of Connecticut Health Center
RECRUITING

Farmington, Connecticut, 06030, United States
University of North Carolina at Chapel Hill
RECRUITING

Chapel Hill, North Carolina, 27514, United States
University of Pennsylvania
RECRUITING

Philadelphia, Pennsylvania, 19104, United States
University of Vermont Medical Center
RECRUITING

Burlington, Vermont, 05401, United States
Yale University
RECRUITING

New Haven, Connecticut, 06519, United States

Conditions

Explore the condition pages connected to this study.

CARCINOMA, NON-SMALL-CELL LUNG